Protease Inhibitors

Fluorescein-PEG6-NHS ester is a fluorescein labeled PEG derivative containing a NHS group, which enables labeling for antibodies and other purified proteins at primary amines (lysine side chains). The hydrophilic PEG spacer arm increases solubility

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).Appearance:SolidIC50&amp: Target:Protease Cleavable CleavableIn Vitro:ADCs are comprised of an antibody to which is attached an ADC

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).Appearance:SolidIC50&amp: Target:Protease Cleavable CleavableIn Vitro:ADCs are comprised of an antibody to which is attached an ADC

Fmoc-Glu-(Boc)-Val-Cit-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).Appearance:SolidIC50&amp: Target:Protease Cleavable CleavableIn Vitro:ADCs are comprised of an antibody to which is attached an ADC

Fmoc-NH-PEG11-CH2CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.Appearance:Viscous liquidIC50&amp: Target:PEGsIn Vitro:PROTACs contain two different ligands connected by a linker: one is a ligand for an E3

Fmoc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)In VitroADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. MCE has not independently confirmed the

Fmoc-Val-Ala-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)In VitroADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. MCE has not independently confirmed the

A cell-permeable thiooxodihydropyrimidinedione compound that inhibits both formin-mediated, profilin-independent actin nucleation (IC 50 ~15 &#181M using mDia1 or mDia2) and formin-mediated elongation of actin filaments in the presence of profilin

Fructose-proline is an Amadori compound having the potential to alter cellular adhesion, inhibit cancer metastasis and induce apoptosis.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.

FT206 is an inhibitor of carboxamides as ubiquitin-specific protrase extracted from patent WO 2020033707 A1, example 11-1Form:SolidIC50&amp: Target:Carboxamides as ubiquitin-specific protrase.